The "YAP1 Gene Coloboma Ocular with or without Hearing Impairment, Cleft Lip/Palate, and/or Mental Retardation Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify mutations in the YAP1 gene, which have been associated with a spectrum of developmental anomalies including ocular coloboma, hearing impairments, cleft lip and/or palate, and in some cases, mental retardation. The genetic test is crucial for early diagnosis and management of these conditions, enabling tailored medical and supportive care for affected individuals. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed genetic insights it provides. By pinpointing specific genetic mutations, the test aids in the understanding of the condition's etiology, guiding treatment options and genetic counseling for families.
The "TENM1 Gene Colobomatous Microphthalmia Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TENM1 gene that are associated with colobomatous microphthalmia. Colobomatous microphthalmia is a rare, congenital eye disorder characterized by the underdevelopment of the eye (microphthalmia) and missing pieces of tissue in structures of the eye (coloboma). These conditions can lead to significant visual impairment or blindness. The TENM1 gene plays a crucial role in eye development, and mutations in this gene are linked to the occurrence of these disorders.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the TENM1 gene. This genetic testing is crucial for early diagnosis, which can significantly aid in the management and treatment of the condition, offering insights into the prognosis and potential interventions to improve the quality of life for affected individuals.
The cost of the TENM1 Gene Colobomatous Microphthalmia Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the advanced technology employed in analyzing the genetic material, and the professional expertise required to interpret the results. Patients seeking this test can expect a comprehensive service that includes not only the genetic analysis but also pre-test and post-test counseling to understand the implications of the results. This genetic test is a valuable tool for families with a history of colobomatous microphthalmia, offering them critical information for family planning and management of the condition.
The AIPL1 gene cone-rod dystrophy genetic test is a specialized diagnostic tool designed to identify mutations in the AIPL1 gene, which are known to cause cone-rod dystrophy. Cone-rod dystrophy is a group of inherited eye disorders that affect the cone and rod cells of the retina, leading to progressive vision loss. The AIPL1 gene plays a crucial role in the health and function of photoreceptor cells in the eye, and mutations in this gene can disrupt these cells' normal functioning, resulting in the symptoms associated with cone-rod dystrophy.
This genetic test is crucial for early diagnosis and management of the condition, allowing for better understanding of the prognosis and potential interventions to manage symptoms. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in a laboratory for the presence of mutations in the AIPL1 gene.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the AIPL1 gene cone-rod dystrophy genetic test is 4400 AED. This investment can provide invaluable information for affected individuals and their families, offering insights into the genetic underpinnings of their condition and guiding decisions about treatment and management.
The UNC119 gene cone-rod dystrophy genetic test is a specialized diagnostic procedure designed to identify mutations in the UNC119 gene, which are linked to cone-rod dystrophy, a group of inherited eye disorders. These disorders primarily affect the cone and rod cells in the retina, leading to a progressive loss of vision. Symptoms often include decreased visual acuity, loss of color vision, and night blindness, eventually progressing to legal blindness in many cases.
The test is particularly valuable for individuals with a family history of cone-rod dystrophy or for those exhibiting symptoms, as it can provide a definitive diagnosis and help in managing the condition more effectively. Additionally, it can be essential for family planning purposes, offering at-risk couples the information needed to make informed decisions about having children.
Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, the UNC119 gene cone-rod dystrophy genetic test is performed with high accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to identify mutations in the UNC119 gene accurately. Upon completion, the results can offer critical insights into treatment options and potential interventions, although it's important to note that currently, there is no cure for cone-rod dystrophy, and treatments mainly focus on managing symptoms and slowing progression.
The RAX2 Gene Cone-Rod Dystrophy Type 11 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RAX2 gene, which are implicated in the development of Cone-Rod Dystrophy Type 11. This condition is a rare form of inherited eye disorder that predominantly affects the cone and rod cells in the retina, leading to progressive vision loss. The test plays a crucial role in the early detection and management of the disorder, offering insights into potential treatments and interventions to slow the progression of the disease. The cost of the test is set at 4400 AED, reflecting the advanced genetic analysis involved in identifying the specific mutations within the RAX2 gene. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test is a significant step forward in personalized medicine, providing patients and their families with crucial information about their genetic health and the risk of inheriting or passing on Cone-Rod Dystrophy Type 11.
The PROM1 Gene Cone-Rod Dystrophy Type 12 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the PROM1 gene, which are implicated in the development of Cone-Rod Dystrophy Type 12 (CRD12). This condition is a form of inherited eye disorder that primarily affects the cone and rod cells of the retina, leading to progressive vision loss. The test is crucial for individuals with a family history of CRD12 or those exhibiting symptoms of the disorder, as it provides a definitive diagnosis by analyzing the genetic makeup for specific anomalies in the PROM1 gene.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test involves collecting a DNA sample, usually through a blood draw or cheek swab. The sample is then subjected to comprehensive genetic analysis to detect any mutations associated with CRD12. This information is vital for understanding the risk of developing the condition, potential progression, and guiding decisions regarding management and treatment options.
The cost of the PROM1 Gene Cone-Rod Dystrophy Type 12 Genetic Test at DNA Labs UAE is set at 4400 AED. While the price may seem significant, the value of the information it provides cannot be overstated for affected individuals and their families. It offers a path towards personalized care strategies and, in some cases, might inform decisions about family planning.
The RPGRIP1 Gene Cone-Rod Dystrophy Type 13 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the RPGRIP1 gene that are associated with Cone-Rod Dystrophy Type 13 (CORD13). Cone-Rod Dystrophy is a group of inherited eye disorders that affect the photoreceptor cells responsible for vision, leading to a progressive loss of visual acuity, color vision, and peripheral vision. The RPGRIP1 gene plays a crucial role in the function and survival of these cells, and mutations in this gene can disrupt normal vision and lead to CORD13.
This genetic test is critical for individuals with a family history of Cone-Rod Dystrophy or those experiencing symptoms related to vision impairment, as it provides a definitive diagnosis by detecting the presence of specific genetic mutations. Early diagnosis through genetic testing can help in managing the condition, understanding the risk of passing it on to future generations, and accessing potential treatment options.
The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of results. The cost of the RPGRIP1 Gene Cone-Rod Dystrophy Type 13 Genetic Test is set at 4400 AED, reflecting the comprehensive analysis and the specialized technology employed in identifying the genetic mutations associated with this condition.
The GUCA1A gene is linked to Cone-Rod Dystrophy Type 14, a rare genetic disorder that affects the retina's ability to respond to light, leading to progressive vision loss. This condition is inherited in an autosomal dominant manner, meaning a mutation in just one copy of the gene can cause the disorder. The GUCA1A Gene Cone-Rod Dystrophy Type 14 Genetic Test is a specialized diagnostic tool designed to identify mutations in the GUCA1A gene that are responsible for the condition. This test is crucial for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding potential treatment and management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA, extracted from a blood sample or cheek swab, to look for specific genetic changes in the GUCA1A gene. The process is comprehensive, ensuring high accuracy in detecting mutations associated with Cone-Rod Dystrophy Type 14.
The cost of the GUCA1A Gene Cone-Rod Dystrophy Type 14 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full process of collecting the sample, conducting the genetic analysis, and providing a detailed report of the findings. The test is a valuable resource for individuals with a family history of the disorder or those experiencing symptoms related to vision loss, offering a clear path to understanding their genetic health and making informed decisions about their future and that of their family.
The CDHR1 gene cone-rod dystrophy type 15 genetic test is a specialized diagnostic procedure designed to detect mutations in the CDHR1 gene, which are associated with cone-rod dystrophy type 15 (CORD15). Cone-rod dystrophy is a group of inherited eye disorders that affect the light-sensitive cells of the retina, leading to progressive vision loss. The CDHR1 gene plays a crucial role in the function and structure of these cells. Mutations in this gene can disrupt normal vision and lead to the early onset of symptoms such as decreased visual acuity, loss of color vision, and night blindness.
This test is particularly important for individuals with a family history of cone-rod dystrophy or those experiencing symptoms suggestive of the disorder. Early and accurate diagnosis through genetic testing can help in managing the condition, understanding its progression, and exploring potential treatment options.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the CDHR1 gene cone-rod dystrophy type 15 genetic test is 4400 AED. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the CDHR1 gene. The results of this test can provide valuable information for affected individuals and their families regarding the diagnosis, prognosis, and potential genetic counseling needs.
The "CD3G Gene Cone-Rod Dystrophy Type 17 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the CD3G gene, which are implicated in Cone-Rod Dystrophy Type 17, a rare genetic disorder. This condition affects the retina, leading to the progressive loss of vision starting with color vision deficits, decreased visual acuity, and loss of peripheral vision, eventually progressing to blindness. The test is crucial for early diagnosis, which can aid in management and understanding the prognosis of the disease.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the CD3G gene to detect any abnormalities that could indicate the presence of Cone-Rod Dystrophy Type 17. The test cost is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the gene. This genetic test is a vital tool for individuals with a family history of the condition or those experiencing symptoms, offering them a clear diagnosis and the possibility of genetic counseling based on their results.
